Navigation Links
KGI Professor Cregg to Be Featured Speaker at Pichia 2012 Conference
Date:10/25/2011

CLAREMONT, Calif., Oct. 25, 2011 /PRNewswire/ -- Keck Graduate Institute (KGI) Research Professor James M. Cregg, PhD, will be the keynote speaker at the upcoming Pichia 2012 conference from February 23 – March 3 in Alpbach, Austria.

Cregg has spent years conducting internationally-renowned research on the development and use of the yeast species, Pichia pastoris, as a system for the production of recombinant proteins.

At the Pichia 2012 Conference he will discuss how the Pichia system began, how it works, and resources available to scientists and drug developers. The event is expected to attract a large audience of global participants from universities, research institutes and companies who wish to exchange ideas on Pichia.

Cregg's work has had a significant impact on the development of pharmaceutical proteins such as chimeric monoclonal antibodies, which work against rheumatoid arthritis, certain cancers and other diseases, as well as human serum albumen, a component of artificial blood plasma.

Many laboratories around the world now use Pichia to make proteins for medical and research applications. Expectations are that within the next decade this yeast expression system will lead to the development of more drugs to combat diseases, according to Cregg.

Cregg has provided keynote addresses at numerous meetings. He serves as a reviewer or editor on five peer-reviewed journals in the biotechnology field: Protein Expression and Purification (executive editor); Applied and Environmental Microbiology; Biotechnology Letters; FEMS Yeast Research; and Molecular Biotechnology.

For more information on the Pichia 2012 conference, visit www.pichia2012.com.

KGI BACKGROUND

Educating the future leaders of the bioscience industry, Keck Graduate Institute (KGI) offers an interdisciplinary graduate education through its Master of Bioscience (MBS), Postdoctoral Professional Masters in Bioscience Management (PPM), Postbaccalaureate Premedical Certificate (PPC), PhD and other academic programs. Using team-based learning and real-world projects, KGI's innovative curriculum seamlessly combines applied life sciences, bioengineering, bioethics and business management. KGI also has a robust research program concentrating on the translation of basic discoveries in the life sciences into applications that can benefit society. KGI is a member of The Claremont Colleges, located in Claremont, California.


'/>"/>
SOURCE Keck Graduate Institute
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. KGI Professor Awarded Patent for Stem-Cell Therapy Aiding Heart-attack Patients
2. Nature offers key lessons on harvesting solar power, says U of T chemistry professor
3. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
4. INRS professor Federico Rosei awarded Rutherford Memorial Medal for Chemistry
5. UT professors pathogen research inspires robotics design for medicine and military
6. UCSB professor receives Presidential Green Chemistry Challenge Award
7. Enhanced electrical energy storage may result from professors research
8. NJIT professor develops a biologically inspired catalyst, an active yet inert material
9. Engineering professor wins award for pioneering work expected to improve electronic devices
10. Grove School professor leads new metamaterials center
11. Queens University professor uses nanotechnology to prolong machine and engine life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... India , January 23, 2017 ... Mouse Model Market by Type (Genetic, Cell-based (CD34, PBMC, ... & End User (Pharmaceutical & Biotech Companies, CRO) - ... studies the global Humanized Mouse Model Market for the ... expected to reach USD 116.0 Million by 2021 from ...
(Date:1/24/2017)... Inc. (NYSE: BIOA ) today announced that ... & Renshaw, a unit of H.C. Wainwright ... of several underwriters, under which the underwriters have agreed ... of 2,105,264 shares of common stock of the Company, ... shares of common stock of the Company with an ...
(Date:1/23/2017)... BOONTON, N.J. , Jan. 23, 2017   ... a feasibility study agreement with Sanofi to ... molecule delivery platform, Peptelligence™, to develop an oral formulation ... Joel Tune , Chief Executive Officer and ... Sanofi is further validation of the tremendous value our ...
(Date:1/23/2017)... ... January 23, 2017 , ... Calvert Labs, ... Preclinical Safety and Senior Director, Safety Pharmacology. Dr. Thomas earned his M.Sc. ... Dr. Thomas’ career as an academic and industry preclinical drug developer spans more ...
Breaking Biology Technology:
(Date:1/19/2017)... and PUNE, India , January 19, 2017 /PRNewswire/ ... titled, "Global Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," the ... at a CAGR of 9.6% from 2016 to 2022. In 2015, ... to high-level security for both public and private sectors. ... ...
(Date:1/13/2017)... , Jan. 13, 2017 Sandata ... solutions for the homecare industry, including Electronic Visit ... industry expert, Justin Jugs, as Senior Vice President ... than 15 years of homecare experience to Sandata, ... developing strategic plans to align Sandata,s suite of ...
(Date:1/11/2017)... Intoxalock, a leading ignition interlock provider, has ... patent-pending calibration device. With this new technology, Intoxalock is ... data logs and process repairs at service center locations, ... drunk driving through the application of cutting-edge technologies is ... also for the customer who can get back on ...
Breaking Biology News(10 mins):